Hotline: 1800 102 2007
Hotline: 1800 102 2007
Search Business Opportunities
Acquisition 2015-04-02

Dr Reddy’s agrees to acquire UCB business in India for Rs800 crore

One of India’s leading drugmaker companies, Dr Reddy’s Laboratories has announced entering into a definitive agreement to acquire Belgium based pharmaceutical firm UCB for a selected portfolio

Dr Reddy’s agrees to acquire UCB business in India for Rs800 crore

Renowned Indian drugmaker, Dr Reddy's Laboratories, has agreed to enter into a definitive agreement with Belgium based pharmaceutical firm UCB in India to acquire a select portfolio for Rs 800 crore.

Reportedly, in a recent statement released by Dr Reddy said the acquisition is on a slump sale basis and the established products business of UCB would cover the territories of India and neighbouring countries like Nepal, Sri Lanka and Maldives.
The brand has also made it vocal that the transaction includes about 350 employees engaged in operations of UCB's India business and the revenue of the acquired business was approx Rs 150 crore for calendar year 2014.

Significantly, the Indian drugmaker said the acquisition of UCB's existing brand equity in the areas of dermatology, respiratory and paediatrics diseases will further expand Dr Reddy's therapy footprint into these fast growing areas. The transaction is expected to be closed in the first quarter of the financial year 2015-16.
"The acquired UCB portfolio shall accelerate Dr Reddy's presence in the high growth areas of dermatology, respiratory and paediatrics with market leading brands like Atarax, Nootropil, Zyrtec, Xyzal, Xyzal M etc," said Alok Sonig, Senior Vice President and India Business Head.

Meanwhile, Mark McDade, Chief Operating Officer (COO), UCB said, "Finding the right company for our established brands in India was crucial, and Dr. Reddy's knowledge of the local market, combined with their ambitious plans and excellent reputation, convinced us they were the right choice to drive this business forward."

McDade Further added, "This position allows us to enhance our focus on our key neurology portfolio in India, providing innovative solutions to patients living with severe diseases."

Listed on Euronext Brussels, UCB has operations in almost 40 countries across the globe with revenues of 3.3 billion Euros in 2014.

Comment
image
image
image
image
Related opportunities
  • About Us: The Arvind Limited Legacy Since 1931, Arvind has been the..
    Locations looking for expansion Gujarat
    Establishment year 2010
    Franchising Launch Date 2010
    Investment size
    Space required 700
    Franchise Outlets -NA-
    Franchise Type MultiUnit
    Headquater Kalol Gujarat
  • Dairy/F&V Stores
    About Us : Moo Cow was started aiming to be the bigest..
    Locations looking for expansion Delhi
    Establishment year 2010
    Franchising Launch Date 2011
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 100
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • About HPS: HPS [Hyderabad Public School Pvt Ltd] is one of..
    Locations looking for expansion Andhra Pardesh
    Establishment year 2009
    Franchising Launch Date 2010
    Investment size Rs. 50lac - 1 Cr.
    Space required 10000
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater 0 Andhra Pardesh
  • Cosmetics & Beauty Product Stores
    About Us: Founded in 2002, in India, KAMA Ayurveda is a..
    Locations looking for expansion Delhi
    Establishment year 2002
    Franchising Launch Date 2018
    Investment size Rs. 30lac - 50lac
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities
More Stories

Free Advice - Ask Our Experts